STUB1 and coronary artery disorder: Notably, the presence of the inhibitory IL-6 receptor gene variant (IL6R p.Asp358Ala) has been shown to reduce CVD risk in DNMT3A and TET2 CHIP carriers by ~50%, suggesting that the inhibition of IL-6 signalling can significantly reduce CAD risk among individuals with CHIP compared to those without [43].